Show simple item record

dc.contributor.authorValladares Ayerbes, Manuel 
dc.date.accessioned2017-06-07T07:09:12Z
dc.date.available2017-06-07T07:09:12Z
dc.date.issued2011
dc.identifier.issn0167-6997
dc.identifier.urihttp://hdl.handle.net/20.500.11940/3174
dc.titleA randomized phase II study of raltitrexed and gefitinib versus raltitrexed alone as second line chemotherapy in patients with colorectal cancer. (1839IL/0143)
dc.typeArtigoes
dc.authorsophosViéitez, J. M.
dc.authorsophosValladares, M.
dc.authorsophosPeláez, I.
dc.authorsophosDe Sande González, L.
dc.authorsophosGarcía-Foncillas, J.
dc.authorsophosGarcía-López, J. L.
dc.authorsophosGarcía-Girón, C.
dc.authorsophosReboredo, M.
dc.authorsophosBovio, H.
dc.authorsophosLacave, A. J.
dc.identifier.doi10.1007/s10637-010-9400-z
dc.identifier.isi294223500035
dc.identifier.sophos9457
dc.issue.number5
dc.journal.titleINVESTIGATIONAL NEW DRUGS
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de A Coruña - Complexo Hospitalario Universitario A Coruña::Oncoloxía médica
dc.page.initial1038
dc.page.final1044
dc.rights.accessRightsopenAccess
dc.typesophosArtículo Original
dc.volume.number29


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record